Our study utilized high-throughput sequencing along with genetic editing to investigate the mechanism of ibrutinib-induced mitochondrial damage leading to AF, with a focus on AKAP1-mediated MQS disturbance. This evidence concerns the gene AKAP1 and atrial fibrillation.